BROADCASTS.com

When Ted Myles is asked to reflect back on his early efforts to land a CFO role \u2013 he arguably sounds a little bit like a safe cracker: \u201cBreaking into the c-suite that first time is always hard,\u201d he explains. \u201cI went in and would continue to get beat out by a sitting CFO,\u201d says Myles, who comments: \u201cUnderstandably \u2013 a board or a CEO is always going to look for someone who\u2019s already proven in the seat.\u201d

Having to date successfully decoded the c-suite\u2019s entry formula not once but four times \u2013 the CFO seat at AMAG Pharmaceuticals is today filled by a seasoned CFO, who is routinely raising the bar for himself as well as AMAG\u2019s finance team.

This past January \u2013 six days into the new year \u2013 AMAG preannounced its 2019 earnings at the annual J.P. Morgan Healthcare Conference in San Francisco \u2013 an energetic gathering where the bio pharmaceutical crowd traditionally kicks off the new year with some blatant chest beating.

\u201cOur accounting team had about six total calendar days to provide us with a tight fix on what the accounting numbers were,\u201d recalls Myles.

\u201cFast forward six weeks after we got through an audit and the numbers were pretty much exactly what we announced six weeks earlier, \u201d explains AMAG\u2019s finance leader, while exhibiting a little extra pride in the biotech firm\u2019s fast and accurate close capabilities. At AMAG, apparently, the ease with which numbers are accessed is as worthy of note as the numbers themselves.\xa0\u2013 Jack Sweeney\xa0

NOW SUBSCRIBE: The Quarterly Digest of CFO Strategic Insight http://bit.ly/2Wfv291 (50 CFO Profiles Every Issue).